Arovella Therapeutics (ASX:ALA) YoY EPS Growth

: 33.33% (As of Dec. 2023)

View and export this data going back to 2002. Start your Free Trial

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Arovella Therapeutics's YoY EPS Growth for the quarter that ended in Dec. 2023 was 33.33%.

Arovella Therapeutics's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was A$-0.00.

Arovella Therapeutics YoY EPS Growth Historical Data

The historical data trend for Arovella Therapeutics's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arovella Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

YoY EPS Growth

18.07

13.24

74.58

-6.67

12.50

Arovella Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
YoY EPS Growth																-33.33	11.11	25.00	-12.50	33.33

Arovella Therapeutics YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Arovella Therapeutics's YoY EPS Growth for the fiscal year that ended in Jun. 2023 is calculated as:

	YoY EPS Growth (A: Jun. 2023 )
=	(Earnings per Share (Diluted) (A: Jun. 2023 )	-	Earnings per Share (Diluted) (A: Jun. 2022 ))	/	\| Earnings per Share (Diluted) (A: Jun. 2022 ) \|
=	(-0.014	-	-0.016)	/	\| -0.016 \|
=	12.50 %

Arovella Therapeutics's YoY EPS Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EPS Growth (Q: Dec. 2023 )
=	(Earnings per Share (Diluted) (Q: Dec. 2023 )	-	Earnings per Share (Diluted) (Q: Dec. 2022 ))	/	\| Earnings per Share (Diluted) (Q: Dec. 2022 )) \|
=	(-0.004	-	-0.006)	/	\| -0.006 \|
=	33.33 %

Arovella Therapeutics YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Arovella Therapeutics's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Arovella Therapeutics (ASX:ALA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arovella Therapeutics Ltd (ASX:ALA) » Definitions » YoY EPS Growth

Comparable Companies

Traded in Other Exchanges

E4NA:Germany

Address

62 Lygon Street, Level 3, Carlton, WA, AUS, 3053

Website

https://www.arovella.com

Arovella Therapeutics Ltd is a biotechnology company focused on developing therapies to treat human diseases. Its two focus areas are oncology and conditions that impact the central nervous system. The company's principal activity is the pharmaceutical development of its invariant Natural Killer T (iNKT) cell platform for the treatment of cancer.

Arovella Therapeutics (ASX:ALA) Headlines

No Headlines